Delivery Order SPE2DB20D2104-SPE2DB25FMYEH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units under a firm fixed-price contract with a ceiling value of $1,225.04. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, non-set-aside procurement. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,837.56 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units, with a ceiling value of $1,225.04. This firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $3,816.36 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the award from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta 50 mg tablets in quantities of 100 units, valued at $1,747.02. This competitively awarded, firm fixed-price contract was established on August 1, 2025, with an ultimate completion date of August 4, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under a larger contract vehicle....
- The Defense Logistics Agency Medical Supply Chain awarded a $4,442.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nucynta (tapentadol) 50mg tablets. This non-set-aside delivery order, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 75mg Nucynta tablets, valued at approximately $8.0K. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, with performance occurring at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement executed through the company's existing contract vehicle with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,849.76 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Nucynta 100 mg tablets (100-count). The contract reflects a firm fixed-price arrangement with an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside delivery order was competitively awarded and represents a routine pharmaceutical procurement within...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,891.14 to AmerisourceBergen Drug Corp for Nucynta ER Tabs 200mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a pediatric procurement under a non-competitive set-aside status and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,944.08 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was competitively...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYEHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,146.04 to AmerisourceBergen Drug Corp for the supply of Nucynta 50 mg tablets (100 count) under a firm fixed-price contract type. This non-set-aside award was executed on August 19, 2025, with an ultimate completion date of August 20, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a single transaction under the company's broader procurement relationship with the federal government for pharmaceutical supply. This award is a child contract stemming from AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. Nucynta (tapentadol) is a centrally acting analgesic used for pain management, consistent with AmerisourceBergen's portfolio of pharmaceutical products delivered through the DLA Medical Supply Chain to support Defense Health Agency operations and other federal healthcare systems. The competitively awarded contract underscores AmerisourceBergen's established capability as a critical pharmaceutical distributor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 8/19/25 |